Human collagen processing and autoimplant use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5332802
SERIAL NO

07897562

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Production of a chemically modified, crosslinkable, telopeptide-containing, naturally crosslinked, solubilized collagen from tissue obtained from a sole human donor, for implanting in the same donor, by chemically modifying the tissue, e.g. by acylation and/or esterification, to form an autoimplantable, crosslinkable, telopeptide-containing, naturally crosslinked, collagen product, as a completely solubilized collagen solution, optionally of high index of refraction for correcting sight or as a partially solubilized collagen suspension; and use of the product for altering the condition of in situ tissue of the same human donor by autoimplantation, such as by crosslinking the product to form an implant device, by placing an effective amount of the product at the tissue site and crosslinking the product in situ, or by partially crosslinking the product and placing an effective amount thereof at the tissue site and optionally further crosslinking the product in situ.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COLLAGEN MATRIX TECHNOLOGIES INC660 GLADES ROAD STE 210 A FLORIDA CORPORATION BOCA RATON FL 33431

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeVore, Dale P Chelmsford, MA 49 2299
Kelman, Charles D Floral Park, NY 77 5615

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation